MicrobiologybioRxiv
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
L. Tostanoski, L. Gralinski, D. Martinez…·D. H. Barouch
This study evaluates the protective efficacy of rhesus adenovirus serotype 52 vaccines against a mouse-adapted SARS-CoV-2 strain, showing robust antibody responses and protection against viral replication and disease.
DOI 10.1128/jvi.00974-21